The company’s first quarter ended Aug. 31. During the first quarter last year, Biomet lost $31.5 million.
Sports, extremities and trauma devices brought much of this year’s profit; the segment earned $149.5 million this year, up 17.4 percent from 2012. Knees were also profitable, bringing in $225.1 million or 3.5 percent more than last year.
More Articles on Devices:
X-Stop Spine Surgery: Outcomes Analysis
19 Spine Devices Get FDA 510(k) Clearance in September
Spine Wave Implements iTraycer for Implants
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
